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ABBREVIATIONS
AHA Assisting Hand Assessment
CCT Controlled clinical trial
CIMT Constraint-induced movement
therapy
EUnetHTA European network for Health
Technology Assessment
MAS Modified Ashworth Scale
mCIMT Modified constraint-induced
movement therapy
PMAL Pediatric Motor Activity Log
QUEST Quality of Upper Extremity
Skills Test
RCT Randomized controlled trial
SDD Smallest detectable difference
AIM The aim of this study was to provide an overview of what is known about constraint-
induced movement therapy (CIMT) in children with unilateral cerebral palsy (CP), to identify
current knowledge gaps, and to provide suggestions for future research.
METHOD Nine experts participated in a consensus meeting. A comprehensive literature
search was conducted and data were summarized before the meeting. The core model
produced by the European network for Health Technology Assessment was used as a
framework for discussion and to identify critical issues for future research.
RESULTS All models of CIMT have demonstrated improvements in the upper limb abilities of
children with unilateral CP. A consensus was reached on 11 important questions to be further
explored in future studies. The areas of highest priority included the effect of dosage, the
effect of repeated CIMT, and the impact of predictive factors, such as age, on the response to
CIMT. Consensus suggestions for future study designs and the use of validated outcome
measures were also provided.
INTERPRETATION The CIMT construct is complex, and much remains unknown. It is unclear
whether a specific model of CIMT demonstrates superiority over others and whether dosage
of training matters. Future research should build upon existing knowledge and aim to
provide information that will help implement CIMT in various countries with different health
care resources and organizational structures.
Over the past decade, interest in constraint-induced move-
ment therapy (CIMT) for children with unilateral cerebral
palsy (CP) has increased dramatically. The number of pub-
lications has grown in this period from a few single case
studies to over 70 studies. However, unlike areas of medi-
cal research that follow a progressive staging of studies to
build on existing knowledge, the development of CIMT
research has been haphazard, consisting of a range of
diverse, often small, trials that rarely build upon each
other. The variation in the content and intensity of CIMT
intervention, as well as the different study designs, make it
extremely difficult to draw conclusions about what the key
aspects of CIMT are and for a comparison of effect to be
made between different CIMT protocols. Importantly,
this limits confidence in choosing a model of CIMT to
implement in clinical practice. The wide range of outcome
measures used and short duration of follow-up also dimin-
ishes the ability to draw conclusions on clinically impor-
tant, real-life effectiveness. Therefore, it is essential to
explore what is currently known about CIMT and identify
the current knowledge gaps that need to be addressed in
order to advance this area of paediatric rehabilitation.
Aims and framework for development of expert
consensus
In January 2012, a group of nine international experts
attended a consensus meeting in Stockholm, Sweden, with
the aim of developing clear recommendations for guiding
future research for CIMT in children with unilateral CP.
A consensus process based on a literature search, a valid
framework to identify key questions of clinical effectiveness
relating to CIMT, and a collaborative discussion among an
© 2013 Mac Keith Press DOI: 10.1111/dmcn.12273 1
international expert group will serve as a useful guide for
future research. As a result this paper aims to (1) identify
the current knowledge gaps regarding CIMT in children
with unilateral CP and (2) present prioritized suggestions
for future research.
METHOD
Preparation of the consensus process
Before the consensus meeting, a literature search was per-
formed (BH). Additionally, with the aim of identifying
clinically relevant, unanswered questions related to CIMT,
a survey was produced using the European network for
Health Technology Assessment (EUnetHTA) and com-
pleted by all members of the consensus group (but IAR).1
Literature review
A comprehensive literature search was conducted to guide
discussion based on the current available literature. Key
search terms were ‘cerebral palsy’, ‘hemiplegia’, ‘CI ther-
apy’, ‘constraint-induced movement therapy’, and ‘forced
use’. The databases that were searched included the Coch-
rane Central Register of Controlled Trials (CENTRAL)
(The Cochrane Library 2011, Issue 3), MEDLINE (up to
January, week 4, 2012), EMBASE (up to January 2012),
CINAHL (up to January, week 4, 2012), and PsychInfo
(up to January, week 4, 2012). In addition, reference lists
of articles and conference abstracts were examined. All
studies published in English, studying children with unilat-
eral CP aged between 0 years and 19 years, and comparing
the effect of any CIMT with a comparison treatment or no
treatment were considered. Additionally, two randomized
controlled trials (RCTs) submitted for publication by con-
sensus group members (BH, KK) were considered. This
search strategy identified 379 articles. Of these, 23 were
RCTs or controlled clinical trials (CCTs) and 45 were
single-group/case study or pretest/posttest designs. During
the consensus meeting, we focused on RCTs and CCTs;
however, content from other studies was considered during
the consensus process when the identified knowledge gaps
needed to be further explored.
Before the meeting, each expert was provided access to
all the literature through a common database. They were
expected to read all publications relating to RCTs and
CCTs (see Table I), and three of these studies were specif-
ically assigned to each expert to be read more carefully,
guided by a list of areas to consider based on the work of
Kunz et al.2 A formal rating of methodological quality for
each trial was not undertaken as the consensus process was
aimed at identifying current knowledge gaps as opposed to
conducting a systematic review or producing guidelines for
clinical practice.3–5
European network for Health Technology Assessment
(EUnetHTA)
To capture a broad perspective of the knowledge on
CIMT, a survey of the EUnetHTA core model for inter-
ventions was completed by each member of the consensus
group. The EUnetHTA project (2006) was developed to
connect public health technology assessment agencies,
research institutions, and health ministries in order to
enhance exchange of information and to support policy
decisions by the EU Member States.1 The EUnetHTA
project has produced a core model that can be used when
deciding upon the implementation of a new intervention
(www.eunethta.eu). The model provides elements and spe-
cific issues (e.g. questions) that have been identified as par-
ticularly significant for decision making including safety,
effectiveness, cost, ethical, social, organizational, and legal
aspects.
The generic survey consisted of a list of 110 issues. Each
issue was rated for relevance regarding consensus discus-
sion (1 = borderline, 2 = moderate, 3 = high) and the need
for future CIMT research (1 = borderline, 2 = moderate,
3 = high). Fifty-seven issues were rated by at least six out
of eight responders as being moderately or highly relevant
for CIMT and requiring further research.
Consensus process for identifying current knowledge
gaps
At the commencement of the consensus meeting, a sum-
mary of outcomes from all RCTs and CCTs was presented
(BH). In addition, a summary of the EUnetHTA survey
was provided, highlighting issues of high or moderate rele-
vance for further discussion (IA-R). Thereafter, the consen-
sus process identified current knowledge gaps. The specific
content of questions to be further explored were prioritized
based on (1) an evaluation of the context-specific impor-
tance of the various issues from the EUnetHTA core
model and (2) a lack of knowledge, guided by the literature
review. When questions were identified by the consensus
group, the literature was specifically reviewed to summa-
rize the existing evidence relating to these questions. Dis-
cussions continued until no further critical questions were
identified. Thereafter, questions were merged into broader
categories, resulting in 11 questions that required further
exploration.
Considerations on the reporting and interpretation of
treatment effects for CIMT and issues relating to the use
of outcome measures were also addressed during the liter-
ature review and consensus process. These were viewed by
the expert group as important for ensuring the quality of
future research in CIMT. To strengthen future research,
we reported on the strengths and limitations of some
commonly used outcome measures and we reported chal-
lenges regarding interpretation of treatment effects across
studies.
What this paper adds
• The CIMT construct remains complex and much is still unknown.
• Consensus agreement identified 11 questions to be explored in future
studies.
• Future research should focus primarily on the effect of dosage, the effect of
repeated treatment, and predictive factors such as age.
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Summary and prioritization process
Following the consensus meeting, discussions continued by
email and Skype until final consensus was reached for each
question. Drafts of a manuscript were continuously sent to
the expert group for review and comment. Upon reaching
a consensus agreement, and as a last stage, independent
prioritization of the importance of each question was
undertaken using an anonymous, web-based survey. Impor-
tance was graded using a 5-point scale, where 1 was least
important and 5 was extremely important. The mean
Table I: List of randomized or controlled clinical trials
Authors Year n
Mean
age
(y:m) Title
Model
classification Comparison
Restraint
type
Taub et al.6 2004 18 3:6 Efficacy of CIMT for children with CP with asymmetric
motor impairment
Signature
CIMT
Usual care Cast
Charles et al.7 2006 22 7 Efficacy of a child-friendly form of CIMT in hemiplegic
CP: a randomized control trial
mCIMT Usual care Sling
Sung et al.8 2005 31 3 Efficacy of forced-use therapy in hemiplegic CP mCIMT Usual care Cast
Smania et al.9 2009 10 3:6 A mCIMT programme improves paretic arm use and
function in children with CP
mCIMT Usual care Mitt
Taub et al.10 2011 20 4 Treatment of congenital hemiparesis with paediatric
CIMT
Hybrid Usual care Cast
Eliasson et al.11 2011 25 2 An ecological approach of CIMT for 2- to 3-year-old
children: a randomized control trial
mCIMT Usual care Mitt
Aarts et al.12 2010 52 5 Effectiveness of mCIMT in children with unilateral
spastic CP: a randomized controlled trial
Hybrid Usual care Sling
Eliasson et al.13 2005 41 2:6 Effects of CIMT in young children with hemiplegic CP:
an adapted model
mCIMT Usual care Mitt
Park et al.14 2009 32 NR The short-term effects of combined mCIMT and
botulinum toxin injection for children with spastic
hemiplegic CP
mCIMT Bimanual Splint
de Brito
Brandao
et al.16
2010 16 6 Adapted version of CIMT promotes functioning in
children with CP: a randomized controlled trial
Hybrid Usual care Bandage
Al-Oraibi et al.17 2011 22 5 Implementation of CIMT for young children with
unilateral CP in Jordan: a home-based model
mCIMT NDT Mitt
Case-Smith
et al.18
2011 18 4 Multicentre randomized controlled trial of paediatric
CIMT: 6-month follow-up
Hybrid Hybrid with
different
intensity
Cast
Gordon et al.19 2011 42 6 Bimanual training and CIMT in children with
hemiplegic CP: a randomized trial
mCIMT HABIT Sling
Lin et al.20 2011 21 7 Effects of home-based CIMT versus dose-matched
control intervention on functional outcomes and
caregiver well-being in children with CP
mCIMT Hybrid Bandage
Rostami et al.21 2011 14 6 Effect of treatment environment on mCIMT results in
children with spastic hemiplegic CP: a randomized
controlled trial
mCIMT mCIMT in
different
environment
Cast
Sakzewski
et al.22
2011 63 10 Randomized trial of CIMT and bimanual training on
activity outcomes for children with congenital
hemiplegia
mCIMT Bimanual Mitt
Wallen et al.23 2011 50 4 mCIMT for children with hemiplegic CP: a randomized
trial
mCIMT Intensive
occupational
therapy
Mitt
Xu et al.24 2011 68 5 Efficacy of CIMT and electrical stimulation on hand
function of children with hemiplegic CP: a controlled
clinical trial
mCIMT Occupational
therapy/
CIMT+ FES
Splint
Hsin et al.25 2012 22 7 Efficacy of CIMT on functional performance and health-
related quality of life for children with CP: a
randomized controlled trial
mCIMT Usual care Mitt
Hoare et al.26 2013 34 3 Intensive therapy following upper limb botulinum
toxin-A injection in young children with unilateral CP
mCIMT Bimanual Mitt
Klingels et al.27 2013 51 9 Randomized controlled trial of mCIMT with or without
therapy guided sessions in children with unilateral CP
Hybrid mCIMT without
therapy
guided
session
Splint
Facchin et al.28 2011 105 3 Multisite trial comparing the efficacy of CIMT with that
of bimanual intensive training in children with
hemiplegic CP post-intervention results
mCIMT Bimanual Mitt
Gordon et al.29 2008 16 7 Both CIMT and bimanual training lead to improved
performance of upper extremity function in children
with hemiplegia
mCIMT HABIT Sling
CIMT, constraint-induced movement therapy; CP, cerebral palsy; mCIMT, modified constraint-induced movement therapy; NR, not
reported; HABIT, hand arm bimanual intensive training.
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values of the nine expert opinions are reported in Figure 1.
Based on these ratings, adjustment of the ‘consensus for
future research’ sections for each question was performed
and the manuscript finalized.
Definition for constraint-induced movement therapy
The literature review identified significant complexity and
confusion relating to the definition of CIMT. The defini-
tions of CIMT concepts used by the consensus group are
described below.
First described by Edward Taub in 1993,30 the origi-
nal, or signature, model of CIMT, has been significantly
adapted for use in children with CP. Across 24 RCTs/
CCTs, 23 studies have altered at least one variable,
including the type and intensity of the restraint of the
well-functioning hand, the type and dosage of structured
training, and the treatment environment. These variables
have all been modified to a different extent to suit local
factors such as organizational, cultural, social, and finan-
cial conditions. More recently there have also been mod-
els that incorporate a bimanual component to training
(either concomitantly or immediately after unimanual
training; see hybrid models, Table I). These models were
developed to improve outcomes of CIMT; however,
adaptations contribute to the complexity of previous
attempts to define models of CIMT in paediatrics and
create difficulties in understanding the specific influence
of each variable.4
In order to distinguish CIMT from other models of
upper limb training, the consensus group proposed two
key ingredients that define CIMT: (1) restraint of the well-
functioning upper limb (irrespective of device/type) and
(2) intensive structured training (irrespective of type).
These key ingredients are found in all models of CIMT but
have been manipulated to various degrees between studies.
For the purpose of this consensus discussion, specific
model types have been categorized according to the defini-
tions detailed below.
Signature constraint-induced movement therapy. Taub’s
original model was initially developed for adults with
hemiparesis following stroke. This involves restraint of the
well-functioning upper limb for 90% of waking hours for
at least 2 weeks, while intensively training the involved
upper limb for 3 hours or more per day.30,31
Modified constraint-induced movement therapy (mCIMT). The
key ingredients (restraint and intensive training) are
included but vary from the signature model. Variables
include: the type of restraint of the well-functioning upper
limb (sling, cast, mitt/glove); the type of structured training
(shaping/repetition, motor learning); the programme dura-
tion (hours per day) and length (number of weeks); and the
location, context, and provider of training (home/camp,
individual/group, therapist/parent).
Hybrid CIMT. The key ingredients are included and
bimanual training is added to different extents. This model
significantly alters the unimanual construct of the method.
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Figure 1: The importance of the defined questions on constraint-induced movement therapy (CIMT), showing the mean value of the nine experts opin-
ions on a 1 to 5 grading scale, where 1 was of least importance and 5 was extremely important.
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Forced use therapy. This involves restraint of the well-func-
tioning upper limb but no specific structured training is
provided. Forced use is related to, but not considered,
CIMT.
Our approach. In this paper, CIMT is used as an umbrella
term when discussing broader issues relating to the treat-
ment including all variations of modified and hybrid
CIMT. Where appropriate, the specific models defined
above have been used. Since forced use therapy does not
include structured training, these studies have been
excluded from the umbrella term CIMT and will be specif-
ically referred to as forced use.
RESULTS
The 11 questions are divided into three groups for future
research, including (1) improving the current knowledge of
the effectiveness of CIMT; (2) differences in variables and
(3) optimal candidates for CIMT. Thereafter, results from
the consensus discussion, with recommendations for future
research, are provided.
Current knowledge on the effectiveness of CIMT
There is evidence from RCTs and CCTs that CIMT, irre-
spective of the model, is effective in improving the upper
limb abilities of children with unilateral CP.6–28,32 There is
no evidence that a specific model of CIMT results in
greater improvement than other models, and no study has
directly compared different models. The broad variation in
key ingredients across studies of CIMT precludes the abil-
ity to establish its effectiveness as a single, distinct inter-
vention. The type of comparison/control group and the
use of 48 different outcome measures makes comparison
between studies difficult. Other factors, such as child char-
acteristics, may also be influenced by outcomes since there
is significant variation in individual response, as demon-
strated by the large standard deviations within all studies.
When CIMT is compared with alternative models of struc-
tured training, such as a bimanual approach, there are
similar improvements in both treatments.19,22,26,29
Improving the current knowledge of the effectiveness of
CIMT
What is known about long-term outcomes following
CIMT?
Literature. Most studies report that improvements after
CIMT are maintained at 3 or 6 months following inter-
vention. Some studies have investigated longer term
effects, with immediate post-treatment gains maintained at
12 months.10,33–35
Consensus for further research. A consistent follow-up period
of 6 months following CIMT facilitates the comparison of
outcomes between studies and is recommended. Follow-up
effects are particularly important when investigating the
effect of dosage (total amount of training performed) as dif-
ferent dosages could possibly yield the same initial effect
but be differentially retained.36 Longer-term follow-up is
difficult with outcomes susceptible to influence from other
treatments and on-going development. Therefore, long-
term comparison between groups does not appear to be an
optimal methodology. As an alternative, we recommend
that a child’s involvement in CIMT programmes should be
documented and described in studies of longitudinal devel-
opment of hand function.
What is known about the effect of repeated CIMT?
Literature. Knowledge of an additive effect from repeated
CIMT is limited.34,37,38 However, when specifically investi-
gated, children were found to maintain improvements from
the first programme of CIMT and make further gains after
a second, with 1 year between programmes.34
Consensus for further research. Further studies investigating
the repeated effects of CIMT are required. One option is
to repeat the same design with 1-year intervals. This will
allow exploration of the dose–response relationship and the
age at which a ceiling effect may be reached. It is also
important to understand how repeated programmes of
CIMT are tolerated by children and their families by mea-
suring the impact on adherence and participation in their
social life.
Do the effects of CIMT transfer to improvements in
bimanual performance and activities of daily life?
Literature. Outcomes from 11 trials using the Assisting
Hand Assessment (AHA), a measure of the efficiency of
the affected hand use in bimanual activities, have demon-
strated clear evidence of the transfer of effect of CIMT to
improvements in bimanual performance (see Table II).
The transfer effect to daily activity performance has also
been demonstrated using parent questionnaires,12,16,17,26
goal attainment measures,12,16,19,23,26 and measures of
occupational performance.12,21,23,26
Consensus for further research. It is recommended that
future studies of CIMT explore the amount of transfer to
skills required for performance of daily activities for chil-
dren with different ability levels.
Differences in variables of CIMT
Does type of restraint matter?
Literature. Across the studies, 19 RCTs/CCTs used
removable devices such as a sling, mitt, splint, or glove
while four used non-removable devices such as casting.
The impact of the restraint may depend on the type of
restraint as well as duration of restraint use. A non-remov-
able cast typically results in a much greater intensity of
unstructured training since it is worn at all times during
the day. Removable restraints have predominantly been
applied only during the structured training period. Cur-
rently, there are no studies directly comparing the effect of
removable and non-removable restraints in combination
with similar amounts of structured training. Compliance
with different types of constraints has also rarely been
investigated. In one study, parents reported that a fabric
mitt, custom made for comfort and fit, was well toler-
ated.39 In a specific investigation of tolerance of the type
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of restraint used (mitt, short and long splint), parents and
children emphasized the importance of comfort with a
long splint being least accepted.40 Irrespective of restraint
type, only a few adverse events have been reported.10,18
Consensus for further research. The potential for superior
effects using non-removable casts compared with remov-
able restraints needs to be investigated. While controlling
for the amount of structured training, the type of restraint
can be varied between groups (24h casting vs removable
restraint only during structured skill training). This will
specifically investigate how the effect of 24-hour restraint
influences the outcome. Investigation of whether the type
of removable restraint has an impact on the effectiveness of
CIMT is also recommended. To a certain extent, a mitt or
a glove allows the use of the well-functioning limb,
whereas a sling excludes the use of this limb, possibly lead-
ing to greater use of the involved hand. It is also recom-
mended that the compliance of the child and family with
different types of restraints be investigated.41 Gaining this
perspective is important in understanding a family’s view
of balancing the burden of CIMT and the treatment effect.
In the absence of current evidence for a superior effect of
any particular type of restraint, the consensus group rec-
ommends that factors such as safety, comfort, climate, fab-
rics, and hygiene should be considered when selecting a
restraint.
Does amount of training matter?
Literature. A fundamental principle of CIMT is the provi-
sion of intensive training to the affected hand.30 Intensity
or dosage of CIMT, however, is not easily defined. To
describe and compare different models of CIMT, hours of
structured training and programme length have typically
been reported as a single unit of intensity (hours), either
consistent or not consistent with hours of wearing the
restraint. This method, however, fails to consider the inter-
action between the duration, frequency and length of the
structured training programme. In this article, we discuss
the amount of training based on (1) duration, the time
(hours) of a single training session; (2) frequency, how
often during the programme period the training is pro-
vided and; (3) length, the numbers of weeks for which the
programme is provided (for further definition see Page
et al.42).
The duration of structured training varies greatly across
studies, from 1 to 6 hours of daily training,18,27 whilst
models of forced use provide no structured training.15,43
To date, the effect of the amount of structured training
has rarely been investigated. Gordon et al.36 reported that
6 hours per day resulted in better outcomes than 2 hours
per day using the same programme length and frequency.
These results contrast with those of Case-Smith et al.,18
who found no difference between groups which received 3
or 6 hours per day of training. Both research groups
compared the same programme length and frequency, but
children in the study by Case-Smith et al. used a non-
removable cast, thereby undertaking additional unstruc-
tured training (i.e. forced use). Therefore, the specific
impact of the amount of structured training may have been
overshadowed by the continuous restraint.
The frequency of daily training across studies is com-
monly five to seven times a week; however, it is sometimes
three times a week.12,21 Across a range of environments,
the reported training includes therapy-guided sessions12 or
supervised training from parents, teachers, students, or
caregivers,11,13 or a mixture of both.26
The length of CIMT programmes varies widely from 2
to 10 weeks. Group-based models of 2 to 3 weeks (training
about 6h/d) have commonly been used for children from
4 years of age and older.7,19,22,29 For younger children
(<4y), models using 2 to 3 hours’ training per day for 6 to
8 weeks have been more commonly used.11,17,23,26 The dif-
ference in effect between short training durations over
longer periods and high training durations over shorter
periods has not yet been investigated.
It is important to recognize that, across studies, the
duration and frequency of training is often not consistent
with the targets specified in each model. For example,
when the training is undertaken in a home or school envi-
ronment, training has been reported to be 40% to 50%
below the target hours.11,13,23,26 Even in structured envi-
ronments such as camps, the duration of active training
achieved has been reported to be only 58%7 or 81%13 of
the target duration.
Consensus for further research. Owing to the multivariable
nature of dosage, the extent to which structured training
influences CIMT outcomes remains unclear. Additional
studies are required to identify the potential existence of a
threshold effect for the amount of structured training. To
investigate the effect of specific aspects of dosage, the dura-
tion of structured training, frequency of training, and pro-
gramme length need to be independently varied within the
same model of CIMT. This can be investigated by varying
the hours of structured training between groups (e.g. 30h vs
60h) while maintaining the same programme frequency and
length and type of restraint.18 Equally, the distribution of
training needs to be investigated by varying programme
length whilst keeping the same duration and frequency of
structured training and the same type of restraint (e.g. a
total of 60h of daily training over 2 or 8wks).
Does the type of structured training matter?
Literature. The type of training varies significantly across
models of CIMT, with all resulting in positive outcomes.
The signature model of CIMT strictly includes shaping
and repetition. Timers and logs are used to carefully moni-
tor the temporal aspects of task performance.44 In modified
models of CIMT, principles of motor learning are more
commonly used.11–13,26 Training can be organized using
activities chosen for training specific movements or hand
skills or training can be focused more on the child’s/ado-
lescent’s preference for play or activities that are then
adapted to ensure success. To date, no study has directly
compared the effect of different training concepts.
Review 7
Consensus for further research. It is recommended that
training concepts should be investigated by using a consis-
tent duration, frequency, and length of training, but varia-
tion should be included in the training model. For
comparison across models and translation into clinical
practice, a precise description of the training needs to be
documented. It is likely that the future development of
CIMT will see innovation in the training methods (e.g.
virtual reality and computer games)45 and continued inte-
gration of bimanual training in conjunction with, or imme-
diately after, CIMT (i.e. hybrid models).10,12,18
Does the environment and context of the training matter?
Literature. Efforts to adapt models of CIMT to become
child and family friendly have resulted in considerable vari-
ation in the location and context in which training is pro-
vided. Group-based training programmes – embedded in
circus groups, pirate groups and recreational/camp envi-
ronments – have been popular, and these techniques have
the aim of improving engagement and motivation.12,19,22,46
There have also been individual-based models using the
child’s daily environment (home, day care, school).11,23,26
The impact of the environment has rarely been investi-
gated, with one small study that compared the impact of a
home-based and clinic-based CIMT finding that outcomes
favoured the home programme.21
Consensus for further research. Variation in the environment
and the location between CIMT models appears to be
based on age as well as practical, financial, and ideological
reasons. Further investigation of how different environ-
ments influence treatment efficacy, compliance, and moti-
vation for CIMT is recommended.
Does the provider of structured training matter?
Literature. The qualifications and number of providers for
structured training vary across studies and include occupa-
tional therapists, physiotherapists, other professionals,
interventionists (specially trained but not qualified), stu-
dents, or parents. Who provides structured training is an
important issue for implementation of CIMT into clinical
practice owing to resource implications. Studies with large
effect sizes support the premise that, after education and
supervision, parents/teachers can be effective providers of
CIMT.11,13 No difference in outcomes was identified
when comparing CIMT provided by qualified therapists or
interventionists.19,36
Consensus for future research. The numbers of therapists/
interventionists responsible for each child, for example a
ratio of 1:1 or 3:1 (i.e. keeping children active with individ-
ualized attention), may influence the effects of training and
is recommended for further investigation.
Optimal candidates for CIMT
Does age influence outcome?
Literature. The mean age of children across studies ran-
ged from 2 to 7 years; however, studies have also included
children as young as 7 months6 while others have included
adolescents.22 In the only direct investigation of the effect
of age, Gordon et al.32 found no difference between out-
comes in children aged 4 to 8 years compared with those
aged 9 to 13 years. In other studies, a correlation of out-
comes with age suggests inconsistent results, most likely
owing to a small variation in age and a large variation in
individual response to CIMT.11,13,22,26 When comparing
the results from a study including the youngest children
(mean age 29mo) with a study including the oldest (mean
age 10y 2mo), the effects measured using the AHA are
somewhat better for the younger age group.11,22 Based on
the knowledge derived from the group data across studies,
it is only possible to conclude that children of all ages ben-
efit from CIMT. Theoretically, enhanced neuroplasticity
of the young brain supports the assertion that ‘the younger
the better’ for initiating CIMT.47 It is also known that the
highest rate of development of the affected hand in biman-
ual activities occurs before 3 years of age in more capable
children, although it appears to plateau at 7 years of age.48
This raises the possibility of a greater training effect in
periods where rapid development commonly occurs.26,35
However, from a practical perspective, older children
may be more able to engage in highly intensive CIMT
programmes and, contextually, group dynamics and team-
work may assist in their motivation and willingness to
participate.41
Consensus for further research. The response to CIMT for
children of different ages requires further investigation.
Large studies including children across a broad age range
would therefore be preferable. As this may not be possible,
studies with distinct age groups could be used to compare
age response with the same models of CIMT,32 for exam-
ple, 2 to 3 years, 7 to 8 years, and 15 to 18 years of age.
The clear gap between age groups may clarify the effect of
age on response to CIMT.
Does severity of impairment influence outcomes?
Literature. Studies of CIMT have generally included par-
ticipants with moderately impaired hand function. Consis-
tent with this, inclusion criteria have commonly adopted
similar guidelines to studies of adults following stroke,
including the ability to actively extend the wrist to 20°.
This is a criterion now validated as the primary predictor
of a successful response to CIMT in adults.49 However, no
such criterion has yet been identified for children with uni-
lateral CP. Although several RCTs/CCTs including chil-
dren with all levels of impairment have demonstrated
positive outcomes following CIMT, the impact of severity
on response to treatment remains unclear.11,13,50
Consensus for further research. Further research is needed to
explore the primary predictors of positive change in order
to identify the optimal group of children who respond pos-
itively to CIMT. Owing to limitations in task performance,
participation in highly intensive CIMT programmes may
be challenging for children with severe motor impairment.
Similarly, the ability of children with cognitive impairment
to maintain attention, follow instructions, and engage in
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some models of CIMT may limit participation. For more
severely involved children, modified, less intense models
have shown positive outcomes.12,13 Existing models of
CIMT may need further adaptation to include the partici-
pation of severely impaired children.
Do lesion characteristics and corticospinal projections
influence outcome?
Literature. There is evidence that the development of
hand function is influenced by the type of brain lesion;
however, the impact on outcomes following CIMT is
unknown.51,52 Different motor projection patterns are also
known to influence the rate of development of hand func-
tion with a correlation between preserved contralateral
motor projection patterns and good hand function.51 It is
plausible that the organization of corticomotor projections,
as well as the type of brain lesion, might influence the
response to CIMT. Kuhnke et al.53 suggest that an increase
in the speed of performance after CIMT seems to be related
to the presence of contralateral corticomotor projections.
However, more recent studies have shown that children,
irrespective of motor projection patterns, can improve
both the speed and the quality of movement (Islam ML,
Nordstrand L, Holmstrom L, Kits A, Forssberg H, and
Eliasson A, unpublished data).
Consensus suggestion for further research. Brain imaging and
neurophysiological techniques are recommended to be
used in future studies of CIMT to further explain the neu-
rophysiological and structural prerequisites for effective
treatment. These studies will also assist in defining the
impact of neurological factors on the response to CIMT.
Prioritization of the defined questions
Of the 11 important questions identified, some were con-
sidered a higher priority by the group of experts to address
in future research (Fig. 1). No question scored below a 3
on the 1- to 5-point scale of importance, indicating all
were considered important. Three questions were identi-
fied as extremely important and require priority for further
investigation: the influence of age on treatment effect
(question 9); the effect of repeated CIMT (question 2); and
whether the amount of training matters (question 5). The
concept of intensive bursts of training across childhood
seems promising. However, the interaction between pro-
gramme length, duration, and frequency remains unclear.
Focused studies targeting these variables using two experi-
mental groups rather than a control group are now
required. The consensus group recommends that future
research prioritize these specific research questions in
future studies.
It was recognized by further discussion that the type of
restraint (question 8) is of high relevance for clinical imple-
mentation and requires further investigation. The question
is whether non-removable restraints (i.e. casting) is more
effective than periodic constraint. Likewise, comparison
between forced use (i.e. casting and no training) and CIMT
is important. The type of restraint used, in particular casting
or removable devices, has raised mixed feelings among both
clinicians and researchers owing to the perceived differences
in efficacy, ethical concerns, and issues around compliance
and child friendliness. Until potential differences in the
effect of casting versus periodic restraint are known, it will
not be possible to address these important issues.
Finally, important aspects of cost-effectiveness include
who provides CIMT and in which environment CIMT is
implemented. Existing models require different amounts of
therapy-guided treatment, leading to vastly different costs.
Some models require only a few hours of therapy-guided
sessions while others have reported up to 126 hours of
therapy-guided sessions. CIMT can take place in the
child’s daily environment, or in special recreational areas
or hospitals, which has a further impact on cost. Forced
use remains the cheapest model since it does not require
any therapy-guided sessions, any specific location, or any
materials. In future research, the interaction between cost
and effect needs to be considered in addition to compli-
ance and families’ preferences.
Methods for evaluating effectiveness
Measuring outcomes
In the 23 RCTs, as many as 48 different clinical outcome
measures were used, the majority being used by only one
study. Table II lists the 17 tests that have been used in more
than one study. This huge inconsistency prevents the pool-
ing of data and precludes making objective conclusions
about the effectiveness of CIMT. Other problems involve
the use of measures without demonstrated validity, reliabil-
ity, or sensitivity to change for the targeted group of children
with unilateral CP. Furthermore, if the administration or
scoring of a standardized measure has been adapted, the
validity and reliability of the outcome is not maintained and
therefore integrity of the measure is threatened.54
The most commonly used assessments (see Table II) can
be categorized into (1) measures of body function/structure
(grip strength, muscle tone and spasticity [the Modified
Tardieu Scale and the modified Ashworth Scale (MAS)],
and range of motion);55,56 (2) unimanual measures of speed
and dexterity (Bruininks–Oseretsky Test of Motor Profi-
ciency,57 Jebsen–Taylor Test of Hand Function58); (3) uni-
manual measures of quality of movement/skills (Quality of
Upper Extremity Skills Test [QUEST], Melbourne Assess-
ment);59,60 (4) effectiveness of the use of the assisting hand
in bimanual performance (AHA);61 (5) parental question-
naire of the amount and quality of use of the affected arm
(Paediatric Motor Activity Log [PMAL]);6 and (6) individ-
ualized measures of functional performance (Goal Attain-
ment Scaling and the Canadian Occupational Performance
Measure).62,63 Almost all studies report significant
improvements following CIMT with the measures used.
The exception concerns measures of body function
(e.g. tactile sensibility,7,22 range of motion,12,27 and muscle
tone.7,23 Muscle tone and spasticity were generally only
shown to change after CIMT when combined with
anti-spasticity medication such as botulinum toxin-A.14,26
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It was also observed that the frequent use of an outcome
measure was not synonymous with scale validity and/or
reliability.64
Consensus for future research. In order to contribute new
knowledge, we recommend future studies use measures
that allow the comparison of data across studies and which
prioritize outcomes directly targeted by CIMT interven-
tion. The choice of measure should be carefully matched
to expected effects of the CIMT. Both unimanual capacity
and bimanual performance need to be evaluated as primary
outcomes since the CIMT training is focused on unimanu-
al skills but the ultimate goal is to improve functional per-
formance, typically requiring the use of both hands
together. Unimanual object manipulation can be mani-
fested by improved dexterity and speed of performance. In
addition, quality of movements may improve after CIMT.
Assessments evaluating child or parent self-reported opin-
ions are important contributions, bringing knowledge
about the individual’s own perception and experience. Indi-
vidualized outcome measures like Goal Attainment Scaling
often show positive results. However, it is often not possi-
ble to practise activity-related goals, commonly requiring
the use of two hands, within a unimanual CIMT pro-
gramme; therefore, such goal achievement may not be the
result of the CIMT per se.
Strengths and limitations of commonly used tests
Commonly used tests (Table II) assessing different aspects
of hand function are described in detail in this section.
The Assisting Hand Assessment measures the bimanual
aspects of hand function in children with a unilateral
impairment: how effectively the affected hand is spontane-
ously used collaboratively with the well-functioning hand
to perform bimanual tasks. Thus, the AHA measures
important aspects that CIMT aims to improve and pos-
sesses strong psychometric properties, demonstrated in sev-
eral studies.61,65 Availability of the AHA is, however,
limited by the need for a training course. Previous AHA
results are inconsistently reported across studies using dif-
ferent types of scores. The interval-level logit, based on a
0 to 100 AHA-unit scale, is now recommended for report-
ing outcomes.66
The Paediatric Motor Activity Log is a parental report
of how often and how well a child uses the more affected
upper extremity after CIMT in (mostly) unimanual tasks.6
The limitations are that the rationale and validity of the
scale, the underlying theoretical construct, and how item
selection was performed are not known.67 Moreover, some
items in the scale do not appear to be relevant to children
across the age span used (7mo–8y of age). In different
CIMT studies, both the original or modified/revised ver-
sions of the PMAL have been used without description of
the reason or nature of the modification.64 This makes
interpretation of the results and comparison of the data
across studies difficult.
The Jebsen–Taylor Test of Hand Function is a
unimanual capacity measure of speed and dexterity.57 This
is important for the hand function aspect, and the test is fre-
quently used in clinical trials with children with unilateral
CP. However, additional psychometric data are needed for
this population.68,69 Information about test–retest reliability
is still lacking, which is important for speed-related tests for
children of different ages and with fluctuating muscle tone.
The Quality of Upper Extremity Skills Test measures
the quality of movement, aiming to capture changes in
grasp patterns, occurring before 18 months of age, and
qualities of movements addressed in Neurodevelopmental
Therapy (NDT)/Bobath treatment, for example, (1) disso-
ciated movements; (2) protective extension; and (3) weight
bearing.59 Whether these aspects of hand/arm use are
expected to change after CIMT should be considered.
Psychometrics for the QUEST are established for the total
scores involving both hands. Only the subscales for grasp
and dissociated movements are commonly used in CIMT
studies, and frequently for the affected hand only. These
departures from standardized administration and scoring
may invalidate outcomes of the QUEST. In a recent study
using specially trained therapists, interrater reliability levels
for the different domains were acceptable for group com-
parisons, except for the commonly used grasp domain.70
The low reliability for this domain is possibly a result of
scoring categories adopting typically developing grasp pat-
terns, whereas grasp patterns in children with CP often
look and develop differently.70
The Melbourne Assessment of Unilateral Upper Limb
Function rates quality of movement in a single upper
limb.60 The items are scored on range, accuracy, dexterity,
and fluency of movements. Two-thirds of the items making
up the sum score are related to reaching and arm move-
ments, with the rest related to grasp/release. The relatively
low number of grasp and release items might reduce sensi-
tivity to change after CIMT.
The MAS is used to grade muscle tone.55 CIMT has, in
general, not been shown to affect muscle tone. Further-
more, the reliability of the MAS has not been evaluated for
upper limbs in children with CP. However, Klingels
et al.68 found test–retest reliability acceptable for group
level comparisons for composite scores of the individual
muscle groups and for individual muscles of elbow and
wrist flexors. For all other individual muscles, test–retest
reliability was lower. Thus, the consensus group does not
recommended MAS for the evaluation of CIMT.
Reporting the effect of treatment
It is important to be able to compare the effect of the
treatment between different studies. Commonly, authors
report and interpret effect size estimates using Cohen’s
d.71,72 However, depending on the statistical method used,
effect size can also be reported using Pearson’s r, the coef-
ficient of determination (r2), eta squared (g2), or omega
squared (x2).73 In general, the larger the difference and the
smaller the variability between groups, the larger the effect
size. Therefore, for between-group estimations of effect,
the type of control/comparison group significantly affects
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the comparison between studies. For example, CIMT com-
pared with a no treatment/usual-care control group is
expected to result in a larger Cohen’s d estimate than
CIMT compared with a control group receiving a treat-
ment of equal intensity (e.g. hand–arm bimanual intensive
therapy). Additionally, if there is high variability in the
response to treatment (perhaps owing to a broad spectrum
of inclusion criteria), the estimates of effect are likely to be
smaller owing to greater variability.
Treatment effect can also be evaluated in relation to the
smallest detectable difference (SDD) for the outcome mea-
sure used. The smaller the SDD, the more sensitive the
outcome measure is to change. At an individual level, a
change on an outcome measure has to be equal to, or big-
ger than, the SDD level to be considered a real change.66
Information about the SDD is available for only some
measures. For the AHA, on the logit-based, 0 to 100
AHA-unit, scale an SDD is 5 units. For the QUEST, the
SDD is reported to be 13.8% for the hemiplegic hand74
and for the Melbourne Assessment the SDD was found to
be 8.9%.74 It is important to emphasize that the SDD is a
quantification of random variation, inherent in all mea-
sures, and should not be confused with a clinically signifi-
cant/important change. This latter is more complicated
and is likely to be different for persons at different ends of
the ability scale.
Consensus for future research. Future studies of CIMT
should report the SDD and the proportion of children
who achieve change greater than this amount, especially
concerning the primary outcome measure, when available.
We also encourage the calculation and reporting of the
effect size and confidence intervals. The use of specific
effect size estimates must be reported in the context of the
analysis conducted.
CONCLUSION
The introduction of CIMT for children with unilateral CP
has led to significant advances in the knowledge of upper
limb intervention; it has clearly shown manual ability
improves after training. Across all studies of CIMT, there
are consistent positive findings. Through this consensus
process, we have defined key ingredients and variables for
CIMT that differ between studies. Based on the knowledge
gaps in the literature and using the EUnetHTA frame-
work, 11 questions of importance were identified and pri-
oritized with the aim of guiding future research for CIMT.
Further research should be highly prioritized towards
(1) the effect of age on the treatment effect; (2) the effect of
repeated CIMT; and (3) whether the amount of structured
training matters. It should be highlighted that all existing
models of CIMT can be used to further investigate these
recommended questions, since all models are found to be
effective. When using an existing model to further explore
a question, it is important to ensure that only one of the
variables is changed. A multitude of variables interacting
within, and between, models creates significant confusion
about what specific factors contribute to improvement.
Although not included in the prioritization process,
methodological issues are essential for consideration in
future research. It is important to select appropriate out-
come measures. Measures should be related to the nature
and goals of CIMT and, importantly, they should also be
known to be reliable, valid, and responsive to change in
children with CP. For the comparison of outcomes
between studies, the consensus group also recommends the
use of valid tools that have been used as primary outcomes
in previous studies along with the addition of new valid
and reliable measures as they are introduced.
No international guidelines exist for the implementation
of CIMT into clinical practice, and very little is known
about what the effect of treatment means in a child’s life.
What happens when CIMT is applied by a range of clini-
cians with different experience and education and in a
more heterogeneous sample of children in clinical practice
remains unknown. Whilst we recognize the importance of
scientific freedom, we hope that the outcome of our con-
sensus will result in more planned and systematic explora-
tion of unanswered questions relating to CIMT.
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